Reuters Health News Summary

Scientists in Britain have used gene-editing techniques to stop bird flu spreading in chicken cells grown in a lab - a key step towards making genetically-altered chickens that could halt a human flu pandemic. Amgen drug shows high response rate in small lung and colon cancer trial

An experimental Amgen Inc drug that targets a specific genetic mutation significantly reduced tumor size in half of evaluated patients with advanced lung cancer in a small, early-stage trial, researchers said on Monday, sending the U.S. biotechnology company's share up nearly 6 percent. Wall Street has taken a keen interest in the Amgen drug, which could become the first approved medicine targeting a mutated form of a gene known as KRAS - one of the most common mutations found in non-small cell lung cancer (NSCLC). China reports H5N6 bird flu outbreak in Xinjiang

China has confirmed an outbreak of highly pathogenic H5N6 bird flu in Horgos in the far western Xinjiang region. The outbreak killed 1,015 out of 2,545 birds raised by farmers in Horgos, according to a notice on the website of the Ministry of Agriculture and Rural Affairs late on Friday. Merck wins U.S. FDA approval for expanded use of antibiotic

The U.S. Food and Drug Administration said https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-hospital-acquired-and-ventilator-associated-bacterial-pneumonia on Monday it approved expanded use of Merck & Co Inc's antibiotic to treat hospital-acquired pneumonia in patients 18 years and older. The approval is based on the treatment's late-stage trial results, which showed that Merck's drug, Zerbaxa, was as effective as another antibacterial drug. Seattle Genetics, Astellas drug rapidly shrinks tumors in bladder cancer study

An experimental drug developed by Seattle Genetics Inc and Astellas Pharma Inc led to significant, rapid tumor shrinkage in patients with advanced bladder cancer who had been previously treated with immunotherapy and chemotherapy in a midstage trial, according to data presented on Monday. Seattle Genetics shares rose 4.3% to $67.84. Therapy in the office: banks take mental health fight in-house

In 'Billions', a U.S. television show set in the world of hedge funds, traders at the fictional Axe Capital regularly attend sessions with an in-house psychiatrist. In real life, finance professionals are rarely so open about seeking psychological help.